Goldman Sachs
PGEN icon

Goldman Sachs’s Precigen PGEN Stock Holding History

Goldman Sachs’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-63,000
Closed -$412K – 5374
2018
Q4 		$412K Buy
+63,000
New +$706K ﹤0.01% 4475
2016
Q4 		– Sell
-400,876
Closed -$11.1M – 7028
2016
Q3 		$11.1M Sell
400,876
-725,673
-64% -$19.2M ﹤0.01% 2359
2016
Q2 		$27.5M Buy
1,126,549
+1,086,189
+2,691% +$30.8M 0.01% 1562
2016
Q1 		$1.36M Hold
40,360
– – ﹤0.01% 3816
2015
Q4 		$1.21M Buy
+40,360
New +$1.36M ﹤0.01% 4115

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs's PGEN Position: Q2 2026 in Review

Goldman Sachs increased its Precigen (PGEN) stake by 1.7% in Q2 2026, buying an estimated $242K and bringing the position to 3,406,456 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

Goldman Sachs first reported a position in PGEN in Q3 2013 and has held it in 50 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Goldman Sachs held 3,406,456 shares of Precigen worth $19.4M as of Q2 2026.
  • Goldman Sachs bought 55,979 Precigen shares in Q2 2026, an estimated $242K.
  • Precigen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2663 holding.
  • Goldman Sachs first reported a position in Precigen in Q3 2013 and has held it in 50 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.